Esperion Therapeutics (ESPR) Prepaid Assets (2012 - 2026)

Esperion Therapeutics' Prepaid Assets history runs 15 years deep, the most recent figure standing at $5.8 million for Q1 2026.

• Quarterly Prepaid Assets rose 20.27% year-over-year to $5.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.8 million (up 20.27% YoY) and the FY2025 annual result came in at $4.0 million, down 2.67% from the prior year.
• Prepaid Assets was $5.8 million for Q1 2026 at Esperion Therapeutics, up from $4.0 million in the prior quarter.
• Across five years, Prepaid Assets topped out at $14.4 million in Q3 2024 and bottomed at $193000.0 in Q4 2023.
• A 5-year average of $5.5 million and a median of $4.4 million in 2025 frame the typical range for Prepaid Assets.
• Annual changes were most pronounced in 2023 — Prepaid Assets tumbled 98.04% — and 2024, when it soared 2052.85%.
• Esperion Therapeutics' Prepaid Assets stood at $9.9 million in 2022, then plunged by 98.04% to $193000.0 in 2023, then surged by 2052.85% to $4.2 million in 2024, then declined by 2.67% to $4.0 million in 2025, then soared by 43.2% to $5.8 million in 2026.
• Business Quant data shows ESPR's Prepaid Assets at $5.8 million in Q1 2026, $4.0 million in Q4 2025, and $4.4 million in Q3 2025.